Seed oils

Last update: 13 December 2021

(For the archival version of the linoleate hypothesis article, see here.)

Whether the seed oils (also called “vegetable fats”, “n-6 polyunsaturated fats” and similar) are the cause or significant contributor to modern human chronic disease, including obesity, diabetes, coronary heart disease and cancer.

Proposition 1.

It would seem that seed oils cause obesity. In the US, BMI increases have tracked closely with the proportion of added vegetable fats in the food supply1,3,4. Linoleic acid especially seems to be obesogenic14.


It would seem a low proportion of n-3 fatty acids and high proportion of n-6 fatty acids in body tissues (rather than simply n-6 fatty acids per se) cause obesity8.

Proposition 2.

It would seem that seed oils cause diabetes13,17 and oils rich in n-6 fatty acids cause more diabetes than those lower in n-6 fatty acids11. The rise of diabetes in the US is closely associated with the rise of vegetable fats in the diet1,4,18.

Proposition 3.

It would seem that vegetable fats rich in n-6 cause coronary heart disease7, via the oxidation of linoleic acid10.

Proposition 4.

It would seem that linoleic acid is required for cancer to occur24, therefore it causes cancer.

On the contrary,

the Epidemiologist says2, “[…] the cause-and-effect interpretation of our data should not seriously conflict with the generally known facts of the natural history and biology of the disease – in the expression of the Advisory Committee to the Surgeon-General it should have coherence.”

I answer that,

Association doesn’t automatically imply causation, and extrapolation from animal experiments to humans should be done very cautiously. In the case of the seed oils, the association of them and bad things appears to be a historical accident in the United States (in particular), which is notably absent in some other places. Experiments in animals don’t find translation in humans, and even mechanistic studies on human subjects fail to find confirmation in long-term human studies with outcomes of interest.

All this is not to say that polyunsaturated n-6 vegetable fats have no health effects whatsoever (whether positive or negative) – there are many further hypotheses that should be tested – but their impact is vastly overstated by proponents of them as the sole or dominant factor in modern health.

Reply to Proposition 1.

Randomized controlled trials that tested increases in n-6 fats in the diet don’t back up the claim that n-6 fats increase body fatness5,6,7,28.

Reply to proposition 1a.

Randomized controlled trials regarding n-3 supplementation don’t find any difference in adiposity between arms, despite substantial increases in n-3 fatty acids in body tissues in intervention groups9.

Reply to Proposition 2.

Randomized trials find no difference in diabetes incidence or markers when increasing polyunsaturated fats (n-6 and others)23. Higher tissue concentrations of linoleic acid are associated with less diabetes than lower ones19,25. While this last item is not unequivocal evidence that n-6 PUFA protect against diabetes, due to marker competition with effects of diabetes (increased de novo sythesis of non-polyunsaturated fatty acids)20,21, it makes largely untenable the idea that they cause diabetes. Given the known etiology of diabetes progression and remission22, this is also reinforced by the non-obesogenicity of seed oils (shown above).

Reply to proposition 3.

While it is possible to construct a meta-analysis of a small number of trials that shows a trend towards harm7, pooling everything finds very little effect of n-6 on heart disease (including specifically CHD)6. The high variability in study quality and heterogeneity don’t reinforce any solid position of either benefit or harm. Higher tissue and circulating levels of n-6 fatty acids are associated with slightly less cardiovascular disease (including CHD) than lower concentrations, further degrading the proposition that these fats cause such illness12. Finally, coronary heart disease can exist in abundance even in absence of substantial n-6 polyunsaturated intake15,16.

Reply to proposition 4.

There is very little randomized trial data concerning the interaction of n-6 fats and cancer, all of it low quality26. Higher tissue concentrations of linoleic acid are associated with a less cancer mortality than lower ones27, which does not lend much credence either idea that linoleic acid is markedly carcinogenic or that there’s some threshold effect (that applies to humans) at very low intakes.


  1. Guyenet SJ, Carlson SE. Increase in adipose tissue linoleic acid of US adults in the last half century. Adv Nutr. 2015;6(6):660-664. Published 2015 Nov 13. doi:10.3945/an.115.009944
  3. Komlos, J and M Brabec (2010), “The Trend of BMI Values by Deciles of US Adults, birth cohorts 1882-1986” NBER Working Paper 16252.
  4. Putnam, Judy. “Major trends in US food supply, 1909-99.” Food Review/National Food Review 23.1482-2016-121406 (2000): 8-15.
  5. Wanda JE Bemelmans, Jan Broer, Edith JM Feskens, Andries J Smit, Frits AJ Muskiet, Johan D Lefrandt, Victor JJ Bom, Johan F May, Betty Meyboom-de Jong, Effect of an increased intake of α-linolenic acid and group nutritional education on cardiovascular risk factors: the Mediterranean Alpha-linolenic Enriched Groningen Dietary Intervention (MARGARIN) study, The American Journal of Clinical Nutrition, Volume 75, Issue 2, February 2002, Pages 221–227,
  6. Hooper L, Al‐Khudairy L, Abdelhamid AS, Rees K, Brainard JS, Brown TJ, Ajabnoor SM, O’Brien AT, Winstanley LE, Donaldson DH, Song F, Deane KHO. Omega‐6 fats for the primary and secondary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews 2018, Issue 11. Art. No.: CD011094. DOI: 10.1002/14651858.CD011094.pub4. Accessed 12 December 2021.
  7. Ramsden C E, Zamora D, Leelarthaepin B, Majchrzak-Hong S F, Faurot K R, Suchindran C M et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis BMJ 2013; 346 :e8707 doi:10.1136/bmj.e8707
  8. Simopoulos AP. An Increase in the Omega-6/Omega-3 Fatty Acid Ratio Increases the Risk for Obesity. Nutrients. 2016;8(3):128. Published 2016 Mar 2. doi:10.3390/nu8030128
  9. Abdelhamid AS, Brown TJ, Brainard JS, Biswas P, Thorpe GC, Moore HJ, Deane KHO, Summerbell CD, Worthington HV, Song F, Hooper L. Omega‐3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews 2020, Issue 3. Art. No.: CD003177. DOI: 10.1002/14651858.CD003177.pub5. Accessed 12 December 2021.
  10. DiNicolantonio JJ, O’Keefe JH. Omega-6 vegetable oils as a driver of coronary heart disease: the oxidized linoleic acid hypothesis. Open Heart. 2018;5(2):e000898. Published 2018 Sep 26. doi:10.1136/openhrt-2018-000898
  11. Deol P, Evans JR, Dhahbi J, Chellappa K, Han DS, Spindler S, et al. (2015) Soybean Oil Is More Obesogenic and Diabetogenic than Coconut Oil and Fructose in Mouse: Potential Role for the Liver. PLoS ONE 10(7): e0132672.
  12. Marklund M, Wu JHY, Imamura F, Del Gobbo LC, Fretts A, de Goede J, Shi P, Tintle N, Wennberg M, Aslibekyan S, Chen TA, de Oliveira Otto MC, Hirakawa Y, Eriksen HH, Kröger J, Laguzzi F, Lankinen M, Murphy RA, Prem K, Samieri C, Virtanen J, Wood AC, Wong K, Yang WS, Zhou X, Baylin A, Boer JMA, Brouwer IA, Campos H, Chaves PHM, Chien KL, de Faire U, Djoussé L, Eiriksdottir G, El-Abbadi N, Forouhi NG, Michael Gaziano J, Geleijnse JM, Gigante B, Giles G, Guallar E, Gudnason V, Harris T, Harris WS, Helmer C, Hellenius ML, Hodge A, Hu FB, Jacques PF, Jansson JH, Kalsbeek A, Khaw KT, Koh WP, Laakso M, Leander K, Lin HJ, Lind L, Luben R, Luo J, McKnight B, Mursu J, Ninomiya T, Overvad K, Psaty BM, Rimm E, Schulze MB, Siscovick D, Skjelbo Nielsen M, Smith AV, Steffen BT, Steffen L, Sun Q, Sundström J, Tsai MY, Tunstall-Pedoe H, Uusitupa MIJ, van Dam RM, Veenstra J, Monique Verschuren WM, Wareham N, Willett W, Woodward M, Yuan JM, Micha R, Lemaitre RN, Mozaffarian D, Risérus U; Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Fatty Acids and Outcomes Research Consortium (FORCE). Biomarkers of Dietary Omega-6 Fatty Acids and Incident Cardiovascular Disease and Mortality. Circulation. 2019 May 21;139(21):2422-2436. doi: 10.1161/CIRCULATIONAHA.118.038908. PMID: 30971107; PMCID: PMC6582360.
  13. Ghosh S, Qi D, An D, Pulinilkunnil T, Abrahani A, Kuo KH, Wambolt RB, Allard M, Innis SM, Rodrigues B. Brief episode of STZ-induced hyperglycemia produces cardiac abnormalities in rats fed a diet rich in n-6 PUFA. Am J Physiol Heart Circ Physiol. 2004 Dec;287(6):H2518-27. doi: 10.1152/ajpheart.00480.2004. Epub 2004 Jul 29. PMID: 15284064.
  14. Alvheim AR, Malde MK, Osei-Hyiaman D, Lin YH, Pawlosky RJ, Madsen L, Kristiansen K, Frøyland L, Hibbeln JR. Dietary linoleic acid elevates endogenous 2-AG and anandamide and induces obesity. Obesity (Silver Spring). 2012 Oct;20(10):1984-94. doi: 10.1038/oby.2012.38. Epub 2012 Feb 15. PMID: 22334255; PMCID: PMC3458187.
  15. F. B. SHORLAND, PH.D., D.SC., Z. CZOCHANSKA, DIP.AG., I. A. M. PRIOR, M.D., M.R.C.P., F.R.A.C.P., Studies on Fatty Acid Composition of Adipose Tissue and Blood Lipids of Polynesians, The American Journal of Clinical Nutrition, Volume 22, Issue 5, May 1969, Pages 594–605,
  16. YERUSHALMY J, HILLEBOE HE. Fat in the diet and mortality from heart disease; a methodologic note. N Y State J Med. 1957 Jul 15;57(14):2343-54. PMID: 13441073.
  17. van Kempen AA, van der Crabben SN, Ackermans MT, Endert E, Kok JH, Sauerwein HP. Stimulation of gluconeogenesis by intravenous lipids in preterm infants: response depends on fatty acid profile. Am J Physiol Endocrinol Metab. 2006 Apr;290(4):E723-30. doi: 10.1152/ajpendo.00303.2005. Epub 2005 Nov 15. PMID: 16291574.
  18. Harris MI: Prevalence of noninsulin-dependent diabetes and impaired glucose tolerance. Chapter VI In: Diabetes in America, Harris MI, Hamman RF, eds. NIH publ. no. 85-1468, 1985
  19. Mousavi SM, Jalilpiran Y, Karimi E, Aune D, Larijani B, Mozaffarian D, Willett WC, Esmaillzadeh A. Dietary Intake of Linoleic Acid, Its Concentrations, and the Risk of Type 2 Diabetes: A Systematic Review and Dose-Response Meta-analysis of Prospective Cohort Studies. Diabetes Care. 2021 Sep;44(9):2173-2181. doi: 10.2337/dc21-0438. Epub 2021 Aug 20. PMID: 34417277.
  20. Laakso M, Kuusisto J, Stančáková A, et al. The Metabolic Syndrome in Men study: a resource for studies of metabolic and cardiovascular diseases. J Lipid Res. 2017;58(3):481-493. doi:10.1194/jlr.O072629
  21. Schwarz JM, Linfoot P, Dare D, Aghajanian K. Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am J Clin Nutr. 2003 Jan;77(1):43-50. doi: 10.1093/ajcn/77.1.43. PMID: 12499321.
  22. Taylor R. Type 2 diabetes and remission: practical management guided by pathophysiology. J Intern Med. 2021;289(6):754-770. doi:10.1111/joim.13214
  23. Brown T J, Brainard J, Song F, Wang X, Abdelhamid A, Hooper L et al. Omega-3, omega-6, and total dietary polyunsaturated fat for prevention and treatment of type 2 diabetes mellitus: systematic review and meta-analysis of randomised controlled trials BMJ 2019; 366 :l4697 doi:10.1136/bmj.l4697
  24. Ip C, Carter CA, Ip MM. Requirement of essential fatty acid for mammary tumorigenesis in the rat. Cancer Res. 1985 May;45(5):1997-2001. PMID: 3921234.
  25. Wu JHY, Marklund M, Imamura F, Tintle N, Ardisson Korat AV, de Goede J, Zhou X, Yang WS, de Oliveira Otto MC, Kröger J, Qureshi W, Virtanen JK, Bassett JK, Frazier-Wood AC, Lankinen M, Murphy RA, Rajaobelina K, Del Gobbo LC, Forouhi NG, Luben R, Khaw KT, Wareham N, Kalsbeek A, Veenstra J, Luo J, Hu FB, Lin HJ, Siscovick DS, Boeing H, Chen TA, Steffen B, Steffen LM, Hodge A, Eriksdottir G, Smith AV, Gudnason V, Harris TB, Brouwer IA, Berr C, Helmer C, Samieri C, Laakso M, Tsai MY, Giles GG, Nurmi T, Wagenknecht L, Schulze MB, Lemaitre RN, Chien KL, Soedamah-Muthu SS, Geleijnse JM, Sun Q, Harris WS, Lind L, Ärnlöv J, Riserus U, Micha R, Mozaffarian D; Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Fatty Acids and Outcomes Research Consortium (FORCE). Omega-6 fatty acid biomarkers and incident type 2 diabetes: pooled analysis of individual-level data for 39 740 adults from 20 prospective cohort studies. Lancet Diabetes Endocrinol. 2017 Dec;5(12):965-974. doi: 10.1016/S2213-8587(17)30307-8. Epub 2017 Oct 12. PMID: 29032079; PMCID: PMC6029721.
  26. Hanson, S., Thorpe, G., Winstanley, L. et al. Omega-3, omega-6 and total dietary polyunsaturated fat on cancer incidence: systematic review and meta-analysis of randomised trials. Br J Cancer 122, 1260–1270 (2020).
  27. Li J, Guasch-Ferré M, Li Y, Hu FB. Dietary intake and biomarkers of linoleic acid and mortality: systematic review and meta-analysis of prospective cohort studies. Am J Clin Nutr. 2020;112(1):150-167. doi:10.1093/ajcn/nqz349
  28. Pearce ML, Dayton S. Incidence of cancer in men on a diet high in polyunsaturated fat. Lancet. 1971 Mar 6;1(7697):464-7. doi: 10.1016/s0140-6736(71)91086-5. PMID: 4100347.